The group�s principle activities include developing and commercializing cardiovascular therapeutics for treating medical conditions. The group�s products include Saratin and cardiovascular risk reduction products. The group operates from United States.
Executive Information
Name
Title
Email
John Parrish
Dir., CEO, Pres.
N/A
Alison Pilgrim
Chief Medical Officer, VP - Clinical Research, Regulatory Affairs
